Regeneron Pharmaceuticals (REGN) stock: analyst price target and their real reliability
Live quote · data updated Aug 28, 2026
Regeneron Pharmaceuticals · Health Care · ref. ETF XLV · 105 calls · price $807.71
What the company does: Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines to treat various diseases worldwide.
📈 Regeneron Pharmaceuticals (REGN) stock price
$807.71+39.4% over range
Aug 28, 25low $555.51 · high $840.84Aug 27, 26
📏 Click 2 points (left → right) to measure the change · click again to clear.
SellBuy
Buy
71% recommend buying · 17 analysts
📊 JPI status : Regeneron Pharmaceuticals is no longer in our current JPI rankings, but appeared in the past (2021) — its upside may be behind it. See the stocks picked in 2021 →
🎯 REGN price target & analyst consensus — price $808
The price target · all analysts combined (17 targets)
Highest target · 1 firm of 17$1030+27.5%
Median target · of 17 targets$824+2.0%
Lowest target · 1 firm of 17$185-77.1%
Current price$807.71
Where these 17 targets sit · versus the current price · 1 target per firm, last 6 months
Above the price
953%
$824 ↔ $1030
Below
847%
$185 ↔ $795
⭐ What the most reliable analysts say
· those who beat their sector, targets replayed on real prices
⭐ The most reliable of them, either direction: Morgan Stanley — 69% of its targets hit on this sector (825 calls tested). It aims for $758 (-6.2 %), call made on August 1, 2026, maturing on August 1, 2027 (27 d ago).
The 8 reliable analysts
$765-5.3 %
The 9 other firms
$875+8.3 %
How to read it: the 8 reliable firms are not filtered by optimism — 3 aim above the price, 5 below, hence their $765 median. “The 9 others” are the firms that don't pass our reliability filter on this sector.
The consensus · 17 ratings (last 6 months)
Strong Buy00%
Buy1271%
Hold529%
Sell00%
Strong Sell00%
Go deeper on the analysts
🎯 REGN price target all
All 16 calls, one by one, with our verdict on each firm.
→ See all 16 targets, analyst by analyst💡 The best analysts on REGN most reliable
The case for and against, with the numbers, per those who've been right on the stock.
→ Should you invest in REGN? The case for & againstAll analysts (the consensus) · vs · the best (those who've been right)
💬 A question about Regeneron Pharmaceuticals? The JPI assistant answers using our backtest data.
💰 Regeneron Pharmaceuticals dividend
0.58%annual yield
That's ~$3.64 per share per year.
📈 Regeneron Pharmaceuticals fundamentals: valuation, margins & growth › open the full page
P/E 20.2Net margin 27.9 %Revenue growth +16.7 %Cheap for the growth
Revenue, net income and margin per year
Revenue Net income · hover a bar for details
2022
marg. 36 %
2023
Rev +8%Profit −9%
2024
Rev +8%Profit +12%
2025
Rev +1%Profit +2%
🔎 Detailed analyses
✅ Historical analyst reliability on REGN
Hit rate measured on targets already matured (12 months), replayed against real prices. Click a header to sort.
| Firm ↕ | % right i ↕ | Gain vs sector i ↕ | Calls i ↕ |
|---|---|---|---|
| Goldman Sachs ↗ | 100% | +44.0% | 11 |
| Cowen & Co. | 100% | +28.3% | 2 |
| EF Hutton | 100% | +20.2% | 6 |
| Lazard | 100% | +19.5% | 3 |
| Deutsche Bank ↗ | 83% | +45.8% | 6 |
| B of A Securities ↗ | 80% | +42.8% | 15 |
| HC Wainwright & Co. ↗ | 80% | +13.6% | 5 |
| Oppenheimer ↗ | 79% | +16.2% | 14 |
| Morgan Stanley ↗ | 79% | +12.5% | 19 |
| BMO Capital ↗ | 77% | +18.6% | 13 |
See the other 26 firms
| RBC Capital ↗ | 14% | -31.6% | 22 |
| Evercore ISI Group ↗ | 25% | -23.7% | 4 |
| TD Cowen ↗ | 25% | -18.8% | 4 |
| UBS ↗ | 29% | +1.1% | 7 |
| Chardan Capital | 33% | -0.0% | 3 |
| Roth Capital | 33% | +6.5% | 3 |
| Leerink Swann | 40% | +3.2% | 5 |
| Raymond James ↗ | 50% | -3.2% | 2 |
| BTIG ↗ | 50% | +0.3% | 2 |
| Bernstein ↗ | 50% | +1.8% | 6 |
| Canaccord Genuity ↗ | 50% | +5.4% | 10 |
| Cantor Fitzgerald ↗ | 50% | +10.6% | 2 |
| Truist Securities ↗ | 55% | +4.7% | 20 |
| JP Morgan ↗ | 62% | -3.4% | 8 |
| Piper Sandler ↗ | 62% | +4.2% | 13 |
| Wells Fargo ↗ | 64% | +1.3% | 14 |
| Benchmark ↗ | 67% | +5.4% | 3 |
| Barclays ↗ | 67% | +8.3% | 15 |
| Credit Suisse | 67% | +19.1% | 12 |
| Brean Capital | 67% | +21.0% | 6 |
| Jefferies ↗ | 67% | +29.9% | 9 |
| SVB Leerink | 69% | +11.1% | 13 |
| Guggenheim ↗ | 70% | +16.2% | 10 |
| Argus Research ↗ | 75% | +17.6% | 8 |
| Citigroup ↗ | 75% | +22.2% | 8 |
| Baird ↗ | 75% | +29.5% | 4 |
📊 What $1,000 invested in Regeneron Pharmaceuticals would be worth › open the full page
In short — $1,000 invested in Regeneron Pharmaceuticals 10 years ago would be worth $1,149 today, i.e. +1%/yr on average. Best year: 2021 (+31%), worst: 2016 (-32%). Price performance, excluding dividends.
If I'd invested $1,000 in Regeneron Pharmaceuticals
| Investment | Worth today | Gain |
|---|---|---|
| 1 years ago | $875 | -12% |
| 3 years ago | $864 | -14% |
| 5 years ago | $1,291 | +29% |
Return by year (Regeneron Pharmaceuticals)
| Year | Return | $1,000 invested at year start |
|---|---|---|
| 2026 (YTD) | -19% | $808 (-19%) |
| 2025 | +8% | $875 (-12%) |
| 2024 | -19% | $710 (-29%) |
⚠️ Past performance, not predictive nor advice. Prices in $, excluding dividends. Yahoo Finance data.
📰 Recent news on Regeneron Pharmaceuticals
Loading news…
📋 All analyst calls on REGN
Filtered on — · ✕ show all
Leerink Partners ↗
Aug 17, 26
■ Market Perform neutral · not a buy · 🎯$824
Price at call : $805.93 — gap to target +2%
Today : $807.71 — gap to target +2%
🎯 on REGN : 100% (1 call matured) · 📊 on Health : 55.3% · -4.8% (38 calls)
in progress (365j)
matures : Aug 17, 27
matures : Aug 17, 27
■ Neutral neutral · not a buy · 🎯$740
Price at call : $760.66 — gap to target -3%
Today : $807.71 — gap to target -8%
🎯 on REGN : no call matured yet · 📊 on Health : 53.1% · +2.5% (508 calls)
in progress (365j)
matures : Aug 3, 27
matures : Aug 3, 27
Guggenheim ↗
Aug 3, 26
▲ Buy · 🎯$1030
Price at call : $760.66 — upside +35%
Today : $807.71 — upside +28%
🎯 on REGN : 70% (10 calls matureds) · 📊 on Health : 54.6% · +4.4% (97 calls)
in progress (365j)
matures : Aug 3, 27
matures : Aug 3, 27
RBC Capital ↗
Jul 31, 26
■ Sector Perform neutral · not a buy · 🎯$737
Price at call : $759.24 — gap to target -3%
Today : $807.71 — gap to target -9%
🎯 on REGN : 17% (12 calls matureds) · 📊 on Health : 42.8% · -2.4% (395 calls)
in progress (365j)
matures : Jul 31, 27
matures : Jul 31, 27
Morgan Stanley ↗
Jul 31, 26
■ Equal-Weight neutral · not a buy · 🎯$758
Price at call : $759.24 — gap to target -0%
Today : $807.71 — gap to target -6%
🎯 on REGN : no call matured yet · 📊 on Health : 51.5% · +5.2% (825 calls)
in progress (365j)
matures : Jul 31, 27
matures : Jul 31, 27
Cantor Fitzgerald ↗
Jul 31, 26
▲ Overweight · 🎯$795
Price at call : $759.24 — upside +5%
Today : $807.71 — upside -2%
🎯 on REGN : no call matured yet · 📊 on Health : 38.3% · -3.4% (342 calls)
in progress (365j)
matures : Jul 31, 27
matures : Jul 31, 27
Wells Fargo ↗
Jul 31, 26
■ Equal-Weight neutral · not a buy · 🎯$750
Price at call : $759.24 — gap to target -1%
Today : $807.71 — gap to target -7%
🎯 on REGN : no call matured yet · 📊 on Health : 48.5% · +1.2% (392 calls)
in progress (365j)
matures : Jul 31, 27
matures : Jul 31, 27
Truist Securities ↗
Jul 31, 26
▲ Buy · 🎯$772
Price at call : $762.63 — upside +1%
Today : $807.71 — upside -4%
🎯 on REGN : 33% (12 calls matureds) · 📊 on Health : 49.6% · +2.3% (260 calls)
in progress (365j)
matures : Jul 31, 27
matures : Jul 31, 27
See the other 97 calls, newest to oldest
Guggenheim ↗
Jul 21, 26
▲ Buy · 🎯$1000
Price at call : $651.18 — upside +54%
Today : $807.71 — upside +24%
🎯 on REGN : 70% (10 calls matureds) · 📊 on Health : 54.6% · +4.4% (97 calls)
in progress (365j)
matures : Jul 21, 27
matures : Jul 21, 27
Piper Sandler ↗
Jul 9, 26
▲ Overweight · 🎯$854
Price at call : $664.52 — upside +29%
Today : $807.71 — upside +6%
🎯 on REGN : no call matured yet · 📊 on Health : 46.7% · -1.3% (321 calls)
in progress (365j)
matures : Jul 9, 27
matures : Jul 9, 27
Morgan Stanley ↗
Jul 8, 26
■ Equal-Weight neutral · not a buy · 🎯$730
Price at call : $667.95 — gap to target +9%
Today : $807.71 — gap to target -10%
🎯 on REGN : no call matured yet · 📊 on Health : 51.5% · +5.2% (825 calls)
in progress (365j)
matures : Jul 8, 27
matures : Jul 8, 27
RBC Capital ↗
Jul 7, 26
■ Sector Perform neutral · not a buy · 🎯$696
Price at call : $662.88 — gap to target +5%
Today : $807.71 — gap to target -14%
🎯 on REGN : 17% (12 calls matureds) · 📊 on Health : 42.8% · -2.4% (395 calls)
in progress (365j)
matures : Jul 7, 27
matures : Jul 7, 27
Truist Securities ↗
Jul 7, 26
▲ Buy · 🎯$769
Price at call : $676.23 — upside +14%
Today : $807.71 — upside -5%
🎯 on REGN : 33% (12 calls matureds) · 📊 on Health : 49.6% · +2.3% (260 calls)
in progress (365j)
matures : Jul 7, 27
matures : Jul 7, 27
▲ Buy · 🎯$185
Price at call : $676.23 — upside -73%
Today : $807.71 — upside -77%
🎯 on REGN : no call matured yet · 📊 on Health : 47.4% · -1.5% (19 calls)
in progress (365j)
matures : Jul 7, 27
matures : Jul 7, 27
▲ Buy · 🎯$880
Price at call : $676.23 — upside +30%
Today : $807.71 — upside +9%
🎯 on REGN : no call matured yet · 📊 on Health : 53.6% · +1.4% (28 calls)
in progress (365j)
matures : Jul 6, 27
matures : Jul 6, 27
Cantor Fitzgerald ↗
Jul 6, 26
▲ Overweight · 🎯$750
Price at call : $649.81 — upside +15%
Today : $807.71 — upside -7%
🎯 on REGN : no call matured yet · 📊 on Health : 38.3% · -3.4% (342 calls)
in progress (365j)
matures : Jul 6, 27
matures : Jul 6, 27
Canaccord Genuity ↗
May 19, 26
▲ Buy · 🎯$875
Price at call : $649.76 — upside +35%
Today : $807.71 — upside +8%
🎯 on REGN : no call matured yet · 📊 on Health : 53% · +6.1% (151 calls)
in progress (365j)
matures : May 19, 27
matures : May 19, 27
BMO Capital ↗
May 18, 26
▲ Outperform · 🎯$730
Price at call : $630.3 — upside +16%
Today : $807.71 — upside -10%
🎯 on REGN : no call matured yet · 📊 on Health : 60.7% · +8.8% (239 calls)
in progress (365j)
matures : May 18, 27
matures : May 18, 27
Truist Securities ↗
May 18, 26
▲ Buy · 🎯$778
Price at call : $630.3 — upside +23%
Today : $807.71 — upside -4%
🎯 on REGN : 33% (12 calls matureds) · 📊 on Health : 49.6% · +2.3% (260 calls)
in progress (365j)
matures : May 18, 27
matures : May 18, 27
▲ Overweight · 🎯$850
Price at call : $630.3 — upside +35%
Today : $807.71 — upside +5%
🎯 on REGN : no call matured yet · 📊 on Health : 53.8% · +5.3% (355 calls)
in progress (365j)
matures : May 18, 27
matures : May 18, 27
Piper Sandler ↗
May 18, 26
▲ Overweight · 🎯$855
Price at call : $630.3 — upside +36%
Today : $807.71 — upside +6%
🎯 on REGN : no call matured yet · 📊 on Health : 46.7% · -1.3% (321 calls)
in progress (365j)
matures : May 18, 27
matures : May 18, 27
Wells Fargo ↗
May 18, 26
■ Equal-Weight neutral · not a buy · 🎯$700
Price at call : $630.3 — gap to target +11%
Today : $807.71 — gap to target -13%
🎯 on REGN : no call matured yet · 📊 on Health : 48.5% · +1.2% (392 calls)
in progress (365j)
matures : May 18, 27
matures : May 18, 27
RBC Capital ↗
May 18, 26
■ Sector Perform neutral · not a buy · 🎯$707
Price at call : $630.3 — gap to target +12%
Today : $807.71 — gap to target -12%
🎯 on REGN : 17% (12 calls matureds) · 📊 on Health : 42.8% · -2.4% (395 calls)
in progress (365j)
matures : May 18, 27
matures : May 18, 27
■ Neutral neutral · not a buy · 🎯$700
Price at call : $630.3 — gap to target +11%
Today : $807.71 — gap to target -13%
🎯 on REGN : no call matured yet · 📊 on Health : 53.1% · +2.5% (508 calls)
in progress (365j)
matures : May 18, 27
matures : May 18, 27
Leerink Partners ↗
May 18, 26
■ Market Perform neutral · not a buy · 🎯$641
Price at call : $629.68 — gap to target +2%
Today : $807.71 — gap to target -21%
🎯 on REGN : 100% (1 call matured) · 📊 on Health : 55.3% · -4.8% (38 calls)
in progress (365j)
matures : May 18, 27
matures : May 18, 27
Guggenheim ↗
May 1, 26
▲ Buy · 🎯$995
Price at call : $709.21 — upside +40%
Today : $807.71 — upside +23%
🎯 on REGN : 70% (10 calls matureds) · 📊 on Health : 54.6% · +4.4% (97 calls)
in progress (365j)
matures : May 1, 27
matures : May 1, 27
RBC Capital ↗
Apr 30, 26
■ Sector Perform neutral · not a buy · 🎯$762
Price at call : $701.42 — gap to target +9%
Today : $807.71 — gap to target -6%
🎯 on REGN : 17% (12 calls matureds) · 📊 on Health : 42.8% · -2.4% (395 calls)
in progress (365j)
matures : Apr 30, 27
matures : Apr 30, 27
▲ Overweight · 🎯$917
Price at call : $701.42 — upside +31%
Today : $807.71 — upside +14%
🎯 on REGN : no call matured yet · 📊 on Health : 50.1% · +2.2% (629 calls)
in progress (365j)
matures : Apr 30, 27
matures : Apr 30, 27
Truist Securities ↗
Apr 30, 26
▲ Buy · 🎯$796
Price at call : $701.42 — upside +13%
Today : $807.71 — upside -1%
🎯 on REGN : 33% (12 calls matureds) · 📊 on Health : 49.6% · +2.3% (260 calls)
in progress (365j)
matures : Apr 30, 27
matures : Apr 30, 27
Wells Fargo ↗
Apr 30, 26
■ Equal-Weight neutral · not a buy · 🎯$800
Price at call : $707.06 — gap to target +13%
Today : $807.71 — gap to target -1%
🎯 on REGN : no call matured yet · 📊 on Health : 48.5% · +1.2% (392 calls)
in progress (365j)
matures : Apr 30, 27
matures : Apr 30, 27
▲ Buy · 🎯$960
Price at call : $751.57 — upside +28%
Today : $807.71 — upside +19%
🎯 on REGN : no call matured yet · 📊 on Health : 49% · +1.0% (96 calls)
in progress (365j)
matures : Apr 23, 27
matures : Apr 23, 27
Cantor Fitzgerald ↗
Apr 23, 26
▲ Overweight · 🎯$800
Price at call : $751.57 — upside +6%
Today : $807.71 — upside -1%
🎯 on REGN : no call matured yet · 📊 on Health : 38.3% · -3.4% (342 calls)
in progress (365j)
matures : Apr 23, 27
matures : Apr 23, 27
Morgan Stanley ↗
Apr 10, 26
■ Equal-Weight neutral · not a buy · 🎯$796
Price at call : $746.46 — gap to target +7%
Today : $807.71 — gap to target -1%
🎯 on REGN : no call matured yet · 📊 on Health : 51.5% · +5.2% (825 calls)
in progress (365j)
matures : Apr 10, 27
matures : Apr 10, 27
▲ Outperform · 🎯$921
Price at call : $767.85 — upside +20%
Today : $807.71 — upside +14%
🎯 on REGN : 50% (6 calls matureds) · 📊 on Health : 54.7% · +5.2% (64 calls)
in progress (365j)
matures : Apr 8, 27
matures : Apr 8, 27
Truist Securities ↗
Mar 31, 26
▲ Buy · 🎯$801
Price at call : $777.25 — upside +3%
Today : $807.71 — upside -1%
🎯 on REGN : 33% (12 calls matureds) · 📊 on Health : 49.6% · +2.3% (260 calls)
in progress (365j)
matures : Mar 31, 27
matures : Mar 31, 27
▲ Overweight · 🎯$923
Price at call : $759.86 — upside +21%
Today : $807.71 — upside +14%
🎯 on REGN : no call matured yet · 📊 on Health : 50.1% · +2.2% (629 calls)
in progress (365j)
matures : Mar 6, 27
matures : Mar 6, 27
RBC Capital ↗
Mar 2, 26
■ Sector Perform neutral · not a buy · 🎯$765
Price at call : $766.66 — gap to target -0%
Today : $807.71 — gap to target -5%
🎯 on REGN : 17% (12 calls matureds) · 📊 on Health : 42.8% · -2.4% (395 calls)
in progress (365j)
matures : Mar 2, 27
matures : Mar 2, 27
Guggenheim ↗
Feb 9, 26
▲ Buy · 🎯$975
Price at call : $754.91 — upside +29%
Today : $807.71 — upside +21%
🎯 on REGN : 70% (10 calls matureds) · 📊 on Health : 54.6% · +4.4% (97 calls)
in progress (365j)
matures : Feb 9, 27
matures : Feb 9, 27
▲ Overweight · 🎯$950
Price at call : $759.18 — upside +25%
Today : $807.71 — upside +18%
🎯 on REGN : no call matured yet · 📊 on Health : 53.8% · +5.3% (355 calls)
in progress (365j)
matures : Feb 2, 27
matures : Feb 2, 27
Oppenheimer ↗
Feb 2, 26
▲ Outperform · 🎯$865
Price at call : $759.18 — upside +14%
Today : $807.71 — upside +7%
🎯 on REGN : no call matured yet · 📊 on Health : 44.1% · +0.6% (220 calls)
in progress (365j)
matures : Feb 2, 27
matures : Feb 2, 27
Morgan Stanley ↗
Feb 2, 26
■ Equal-Weight neutral · not a buy · 🎯$769
Price at call : $759.18 — gap to target +1%
Today : $807.71 — gap to target -5%
🎯 on REGN : no call matured yet · 📊 on Health : 51.5% · +5.2% (825 calls)
in progress (365j)
matures : Feb 2, 27
matures : Feb 2, 27
Wells Fargo ↗
Feb 2, 26
■ Equal-Weight neutral · not a buy · 🎯$800
Price at call : $759.18 — gap to target +5%
Today : $807.71 — gap to target -1%
🎯 on REGN : no call matured yet · 📊 on Health : 48.5% · +1.2% (392 calls)
in progress (365j)
matures : Feb 2, 27
matures : Feb 2, 27
Cantor Fitzgerald ↗
Feb 2, 26
▲ Overweight · 🎯$800
Price at call : $759.18 — upside +5%
Today : $807.71 — upside -1%
🎯 on REGN : no call matured yet · 📊 on Health : 38.3% · -3.4% (342 calls)
in progress (365j)
matures : Feb 2, 27
matures : Feb 2, 27
Truist Securities ↗
Feb 2, 26
▲ Buy · 🎯$818
Price at call : $759.18 — upside +8%
Today : $807.71 — upside +1%
🎯 on REGN : 33% (12 calls matureds) · 📊 on Health : 49.6% · +2.3% (260 calls)
in progress (365j)
matures : Feb 2, 27
matures : Feb 2, 27
Evercore ISI Group ↗
Jan 22, 26
▲ Outperform · 🎯$875
Price at call : $753.55 — upside +16%
Today : $807.71 — upside +8%
🎯 on REGN : no call matured yet · 📊 on Health : 45.8% · +0.0% (168 calls)
in progress (365j)
matures : Jan 22, 27
matures : Jan 22, 27
Truist Securities ↗
Jan 8, 26
▲ Buy · 🎯$820
Price at call : $796.55 — upside +3%
Today : $807.71 — upside +2%
🎯 on REGN : 33% (12 calls matureds) · 📊 on Health : 49.6% · +2.3% (260 calls)
in progress (365j)
matures : Jan 8, 27
matures : Jan 8, 27
B of A Securities ↗
Jan 7, 26
▲ Buy · 🎯$860
Price at call : $812.27 — upside +6%
Today : $807.71 — upside +6%
🎯 on REGN : no call matured yet · 📊 on Health : 48.3% · +2.0% (356 calls)
in progress (365j)
matures : Jan 7, 27
matures : Jan 7, 27
Morgan Stanley ↗
Dec 12, 25
■ Equal-Weight neutral · not a buy · 🎯$768
Price at call : $752.62 — gap to target +2%
Today : $807.71 — gap to target -5%
🎯 on REGN : no call matured yet · 📊 on Health : 51.5% · +5.2% (825 calls)
in progress (365j)
matures : Dec 12, 26
matures : Dec 12, 26
Wells Fargo ↗
Dec 10, 25
■ Equal-Weight neutral · not a buy · 🎯$745
Price at call : $746.8 — gap to target -0%
Today : $807.71 — gap to target -8%
🎯 on REGN : no call matured yet · 📊 on Health : 48.5% · +1.2% (392 calls)
in progress (365j)
matures : Dec 10, 26
matures : Dec 10, 26
Canaccord Genuity ↗
Dec 4, 25
▲ Buy · 🎯$1057
Price at call : $718.36 — upside +47%
Today : $807.71 — upside +31%
🎯 on REGN : no call matured yet · 📊 on Health : 53% · +6.1% (151 calls)
in progress (365j)
matures : Dec 4, 26
matures : Dec 4, 26
Truist Securities ↗
Aug 11, 25
▲ Buy · 🎯$812
Price at call : $556.55 — upside +46%
Today : $807.71 — upside +1%
Expected +46% · Actual +43% · Reason (≥ +15%) : ✓ Yes
🎯 on REGN : 33% (12 calls matureds) · 📊 on Health : 49.6% · +2.3% (260 calls)
+43.4%
stock +43% · XLV +28%
matured Aug 11, 26
Guggenheim ↗
Aug 4, 25
▲ Buy · 🎯$815
Price at call : $571.54 — upside +43%
Today : $807.71 — upside +1%
Expected +43% · Actual +33% · Reason (≥ +15%) : ✓ Yes
🎯 on REGN : 70% (10 calls matureds) · 📊 on Health : 54.6% · +4.4% (97 calls)
+33.1%
stock +33% · XLV +22%
matured Aug 4, 26
RBC Capital ↗
May 27, 25
▲ Outperform · 🎯$943
Price at call : $591.85 — upside +59%
Today : $807.71 — upside +17%
Expected +59% · Actual +5% · Reason (≥ +15%) : ✗ No
🎯 on REGN : 17% (12 calls matureds) · 📊 on Health : 42.8% · -2.4% (395 calls)
+5.0%
stock +5% · XLV +15%
matured May 27, 26
Guggenheim ↗
May 1, 25
▲ Buy · 🎯$810
Price at call : $605.61 — upside +34%
Today : $807.71 — upside +0%
Expected +34% · Actual +17% · Reason (≥ +15%) : ✓ Yes
🎯 on REGN : 70% (10 calls matureds) · 📊 on Health : 54.6% · +4.4% (97 calls)
+17.1%
stock +17% · XLV +4%
matured May 1, 26
Truist Securities ↗
Apr 30, 25
▲ Buy · 🎯$940
Price at call : $590 — upside +59%
Today : $807.71 — upside +16%
Expected +59% · Actual +19% · Reason (≥ +15%) : ✓ Yes
🎯 on REGN : 33% (12 calls matureds) · 📊 on Health : 49.6% · +2.3% (260 calls)
+18.9%
stock +19% · XLV +6%
matured Apr 30, 26
RBC Capital ↗
Apr 30, 25
▲ Outperform · 🎯$943
Price at call : $590 — upside +60%
Today : $807.71 — upside +17%
Expected +60% · Actual +19% · Reason (≥ +15%) : ✓ Yes
🎯 on REGN : 17% (12 calls matureds) · 📊 on Health : 42.8% · -2.4% (395 calls)
+18.9%
stock +19% · XLV +6%
matured Apr 30, 26
Truist Securities ↗
Apr 23, 25
▲ Buy · 🎯$975
Price at call : $599.76 — upside +63%
Today : $807.71 — upside +21%
Expected +63% · Actual +25% · Reason (≥ +15%) : ✓ Yes
🎯 on REGN : 33% (12 calls matureds) · 📊 on Health : 49.6% · +2.3% (260 calls)
+25.3%
stock +25% · XLV +5%
matured Apr 23, 26
Leerink Partners ↗
Feb 5, 25
▲ Outperform · 🎯$834
Price at call : $716.72 — upside +16%
Today : $807.71 — upside +3%
Expected +16% · Actual +7% · Reason (≥ +15%) : ✗ No
🎯 on REGN : 100% (1 call matured) · 📊 on Health : 55.3% · -4.8% (38 calls)
+7.0%
stock +7% · XLV +4%
matured Feb 5, 26
Truist Securities ↗
Jan 8, 25
▲ Buy · 🎯$1004
Price at call : $733.59 — upside +37%
Today : $807.71 — upside +24%
Expected +37% · Actual +9% · Reason (≥ +15%) : ✗ No
🎯 on REGN : 33% (12 calls matureds) · 📊 on Health : 49.6% · +2.3% (260 calls)
+9.2%
stock +9% · XLV +13%
matured Jan 8, 26
▲ Outperform · 🎯$1070
Price at call : $733.59 — upside +46%
Today : $807.71 — upside +32%
Expected +46% · Actual +9% · Reason (≥ +15%) : ✗ No
🎯 on REGN : 50% (6 calls matureds) · 📊 on Health : 54.7% · +5.2% (64 calls)
+9.2%
stock +9% · XLV +13%
matured Jan 7, 26
RBC Capital ↗
Nov 1, 24
▲ Outperform · 🎯$1215
Price at call : $828.84 — upside +47%
Today : $807.71 — upside +50%
Expected +47% · Actual -23% · Reason (≥ +15%) : ✗ No
🎯 on REGN : 17% (12 calls matureds) · 📊 on Health : 42.8% · -2.4% (395 calls)
-22.5%
stock -23% · XLV -2%
matured Nov 1, 25
Truist Securities ↗
Nov 1, 24
▲ Buy · 🎯$1126
Price at call : $828.84 — upside +36%
Today : $807.71 — upside +39%
Expected +36% · Actual -23% · Reason (≥ +15%) : ✗ No
🎯 on REGN : 33% (12 calls matureds) · 📊 on Health : 49.6% · +2.3% (260 calls)
-22.5%
stock -23% · XLV -2%
matured Nov 1, 25
RBC Capital ↗
Oct 25, 24
▲ Outperform · 🎯$1260
Price at call : $928.61 — upside +36%
Today : $807.71 — upside +56%
Expected +36% · Actual -37% · Reason (≥ +15%) : ✗ No
🎯 on REGN : 17% (12 calls matureds) · 📊 on Health : 42.8% · -2.4% (395 calls)
-37.0%
stock -37% · XLV -2%
matured Oct 25, 25
RBC Capital ↗
Oct 22, 24
▲ Outperform · 🎯$1260
Price at call : $941.39 — upside +34%
Today : $807.71 — upside +56%
Expected +34% · Actual -39% · Reason (≥ +15%) : ✗ No
🎯 on REGN : 17% (12 calls matureds) · 📊 on Health : 42.8% · -2.4% (395 calls)
-38.9%
stock -39% · XLV -3%
matured Oct 22, 25
Truist Securities ↗
Oct 16, 24
▲ Buy · 🎯$1137
Price at call : $998.23 — upside +14%
Today : $807.71 — upside +41%
Expected +14% · Actual -42% · Reason (≥ +15%) : ✗ No
🎯 on REGN : 33% (12 calls matureds) · 📊 on Health : 49.6% · +2.3% (260 calls)
-42.1%
stock -42% · XLV -6%
matured Oct 16, 25
RBC Capital ↗
Oct 4, 24
▲ Outperform · 🎯$1260
Price at call : $996.05 — upside +26%
Today : $807.71 — upside +56%
Expected +26% · Actual -41% · Reason (≥ +15%) : ✗ No
🎯 on REGN : 17% (12 calls matureds) · 📊 on Health : 42.8% · -2.4% (395 calls)
-41.2%
stock -41% · XLV -5%
matured Oct 4, 25
RBC Capital ↗
Sep 24, 24
▲ Outperform · 🎯$1252
Price at call : $1031.15 — upside +21%
Today : $807.71 — upside +55%
Expected +21% · Actual -46% · Reason (≥ +15%) : ✗ No
🎯 on REGN : 17% (12 calls matureds) · 📊 on Health : 42.8% · -2.4% (395 calls)
-46.1%
stock -46% · XLV -12%
matured Sep 24, 25
Truist Securities ↗
Sep 24, 24
▲ Buy · 🎯$1200
Price at call : $1031.15 — upside +16%
Today : $807.71 — upside +49%
Expected +16% · Actual -46% · Reason (≥ +15%) : ✗ No
🎯 on REGN : 33% (12 calls matureds) · 📊 on Health : 49.6% · +2.3% (260 calls)
-46.1%
stock -46% · XLV -12%
matured Sep 24, 25
Leerink Partners ↗
Sep 24, 24
■ Market Perform neutral · not a buy · 🎯$1077
Price at call : $1045.98 — gap to target +3%
Today : $807.71 — gap to target +33%
🎯 on REGN : 100% (1 call matured) · 📊 on Health : 55.3% · -4.8% (38 calls)
in progress (365j)
matures : Sep 24, 25
matures : Sep 24, 25
RBC Capital ↗
Sep 17, 24
▲ Outperform · 🎯$1282
Price at call : $1138.81 — upside +13%
Today : $807.71 — upside +59%
Expected +13% · Actual -47% · Reason (≥ +15%) : ✗ No
🎯 on REGN : 17% (12 calls matureds) · 📊 on Health : 42.8% · -2.4% (395 calls)
-47.4%
stock -47% · XLV -12%
matured Sep 17, 25
RBC Capital ↗
Sep 9, 24
▲ Outperform · 🎯$1282
Price at call : $1136.35 — upside +13%
Today : $807.71 — upside +59%
Expected +13% · Actual -51% · Reason (≥ +15%) : ✗ No
🎯 on REGN : 17% (12 calls matureds) · 📊 on Health : 42.8% · -2.4% (395 calls)
-51.1%
stock -51% · XLV -12%
matured Sep 9, 25
RBC Capital ↗
Sep 5, 24
▲ Outperform · 🎯$1250
Price at call : $1131.5 — upside +10%
Today : $807.71 — upside +55%
Expected +10% · Actual -51% · Reason (≥ +15%) : ✗ No
🎯 on REGN : 17% (12 calls matureds) · 📊 on Health : 42.8% · -2.4% (395 calls)
-50.6%
stock -51% · XLV -10%
matured Sep 5, 25
RBC Capital ↗
Aug 2, 24
▲ Outperform · 🎯$1240
Price at call : $1071.28 — upside +16%
Today : $807.71 — upside +54%
Expected +16% · Actual -47% · Reason (≥ +15%) : ✗ No
🎯 on REGN : 17% (12 calls matureds) · 📊 on Health : 42.8% · -2.4% (395 calls)
-46.7%
stock -47% · XLV -9%
matured Aug 2, 25
Guggenheim ↗
Aug 2, 24
▲ Buy · 🎯$1300
Price at call : $1071.28 — upside +21%
Today : $807.71 — upside +61%
Expected +21% · Actual -47% · Reason (≥ +15%) : ✗ No
🎯 on REGN : 70% (10 calls matureds) · 📊 on Health : 54.6% · +4.4% (97 calls)
-46.7%
stock -47% · XLV -9%
matured Aug 2, 25
Truist Securities ↗
Aug 2, 24
▲ Buy · 🎯$1200
Price at call : $1082.19 — upside +11%
Today : $807.71 — upside +49%
Expected +11% · Actual -47% · Reason (≥ +15%) : ✗ No
🎯 on REGN : 33% (12 calls matureds) · 📊 on Health : 49.6% · +2.3% (260 calls)
-47.2%
stock -47% · XLV -12%
matured Aug 2, 25
Guggenheim ↗
Jul 18, 24
▲ Buy · 🎯$1180
Price at call : $1063.6 — upside +11%
Today : $807.71 — upside +46%
Expected +11% · Actual -49% · Reason (≥ +15%) : ✗ No
🎯 on REGN : 70% (10 calls matureds) · 📊 on Health : 54.6% · +4.4% (97 calls)
-48.7%
stock -49% · XLV -11%
matured Jul 18, 25
Argus Research ↗
Jun 25, 24
▲ Buy · 🎯$1170
Price at call : $1071.19 — upside +9%
Today : $807.71 — upside +45%
Expected +9% · Actual -51% · Reason (≥ +15%) : ✗ No
🎯 on REGN : 75% (8 calls matureds) · 📊 on Health : 55.7% · +2.6% (158 calls)
-51.4%
stock -51% · XLV -9%
matured Jun 25, 25
RBC Capital ↗
Jun 24, 24
▲ Outperform · 🎯$1229
Price at call : $1071.19 — upside +15%
Today : $807.71 — upside +52%
Expected +15% · Actual -51% · Reason (≥ +15%) : ✗ No
🎯 on REGN : 17% (12 calls matureds) · 📊 on Health : 42.8% · -2.4% (395 calls)
-51.4%
stock -51% · XLV -9%
matured Jun 24, 25
Truist Securities ↗
Apr 3, 24
▲ Buy · 🎯$1135
Price at call : $937.02 — upside +21%
Today : $807.71 — upside +41%
Expected +21% · Actual -39% · Reason (≥ +15%) : ✗ No
🎯 on REGN : 33% (12 calls matureds) · 📊 on Health : 49.6% · +2.3% (260 calls)
-38.8%
stock -39% · XLV -5%
matured Apr 3, 25
Truist Securities ↗
Mar 26, 24
▲ Buy · 🎯$1135
Price at call : $966.3 — upside +17%
Today : $807.71 — upside +41%
Expected +17% · Actual -34% · Reason (≥ +15%) : ✗ No
🎯 on REGN : 33% (12 calls matureds) · 📊 on Health : 49.6% · +2.3% (260 calls)
-34.2%
stock -34% · XLV -2%
matured Mar 26, 25
▲ Outperform · 🎯$1125
Price at call : $970.57 — upside +16%
Today : $807.71 — upside +39%
Expected +16% · Actual -29% · Reason (≥ +15%) : ✗ No
🎯 on REGN : 50% (6 calls matureds) · 📊 on Health : 54.7% · +5.2% (64 calls)
-29.0%
stock -29% · XLV -2%
matured Mar 12, 25
▲ Outperform · 🎯$1125
Price at call : $970.57 — upside +16%
Today : $807.71 — upside +39%
Expected +16% · Actual -29% · Reason (≥ +15%) : ✗ No
🎯 on REGN : 50% (6 calls matureds) · 📊 on Health : 54.7% · +5.2% (64 calls)
-29.0%
stock -29% · XLV -2%
matured Mar 11, 25
Truist Securities ↗
Dec 18, 23
▲ Buy · 🎯$1045
Price at call : $848.39 — upside +23%
Today : $807.71 — upside +29%
Expected +23% · Actual -16% · Reason (≥ +15%) : ✗ No
🎯 on REGN : 33% (12 calls matureds) · 📊 on Health : 49.6% · +2.3% (260 calls)
-15.8%
stock -16% · XLV +2%
matured Dec 17, 24
Truist Securities ↗
Nov 29, 23
▲ Buy · 🎯$1045
Price at call : $823.81 — upside +27%
Today : $807.71 — upside +29%
Expected +27% · Actual -9% · Reason (≥ +15%) : ✗ No
🎯 on REGN : 33% (12 calls matureds) · 📊 on Health : 49.6% · +2.3% (260 calls)
-8.9%
stock -9% · XLV +12%
matured Nov 28, 24
Argus Research ↗
Sep 15, 23
▲ Buy · 🎯$920
Price at call : $824.51 — upside +12%
Today : $807.71 — upside +14%
Expected +12% · Actual +40% · Reason (≥ +15%) : ✓ Yes
🎯 on REGN : 75% (8 calls matureds) · 📊 on Health : 55.7% · +2.6% (158 calls)
+39.9%
stock +40% · XLV +20%
matured Sep 14, 24
Guggenheim ↗
Jul 17, 23
▲ Buy · 🎯$900
Price at call : $726.55 — upside +24%
Today : $807.71 — upside +11%
Expected +24% · Actual +49% · Reason (≥ +15%) : ✓ Yes
🎯 on REGN : 70% (10 calls matureds) · 📊 on Health : 54.6% · +4.4% (97 calls)
+49.4%
stock +49% · XLV +14%
matured Jul 16, 24
Guggenheim ↗
May 8, 23
▲ Buy · 🎯$935
Price at call : $754.88 — upside +24%
Today : $807.71 — upside +16%
Expected +24% · Actual +27% · Reason (≥ +15%) : ✓ Yes
🎯 on REGN : 70% (10 calls matureds) · 📊 on Health : 54.6% · +4.4% (97 calls)
+26.6%
stock +27% · XLV +7%
matured May 7, 24
Guggenheim ↗
Nov 11, 22
▲ Buy · 🎯$915
Price at call : $734.45 — upside +25%
Today : $807.71 — upside +13%
Expected +25% · Actual +8% · Reason (≥ +15%) : ✗ No
🎯 on REGN : 70% (10 calls matureds) · 📊 on Health : 54.6% · +4.4% (97 calls)
+8.5%
stock +8% · XLV -5%
matured Nov 11, 23
Argus Research ↗
May 31, 22
▲ Buy · 🎯$760
Price at call : $658.92 — upside +15%
Today : $807.71 — upside -6%
Expected +15% · Actual +11% · Reason (≥ +15%) : ✗ No
🎯 on REGN : 75% (8 calls matureds) · 📊 on Health : 55.7% · +2.6% (158 calls)
+11.0%
stock +11% · XLV -1%
matured May 31, 23
▲ Outperform · 🎯$660
Price at call : $627.1 — upside +5%
Today : $807.71 — upside -18%
Expected +5% · Actual +15% · Reason (≥ +15%) : ✗ No
🎯 on REGN : 50% (6 calls matureds) · 📊 on Health : 54.7% · +5.2% (64 calls)
+14.9%
stock +15% · XLV -3%
matured Jan 3, 23
HC Wainwright & Co. ↗
Nov 5, 21
▲ Buy · 🎯$844
Price at call : $611.54 — upside +38%
Today : $807.71 — upside +4%
Expected +38% · Actual +23% · Reason (≥ +15%) : ✓ Yes
🎯 on REGN : 80% (5 calls matureds) · 📊 on Health : 52.8% · +1.2% (53 calls)
+22.8%
stock +23% · XLV -0%
matured Nov 5, 22
HC Wainwright & Co. ↗
Oct 22, 21
▲ Buy · 🎯$842
Price at call : $576.2 — upside +46%
Today : $807.71 — upside +4%
Expected +46% · Actual +28% · Reason (≥ +15%) : ✓ Yes
🎯 on REGN : 80% (5 calls matureds) · 📊 on Health : 52.8% · +1.2% (53 calls)
+27.9%
stock +28% · XLV -2%
matured Oct 22, 22
HC Wainwright & Co. ↗
Sep 15, 21
▲ Buy · 🎯$831
Price at call : $652 — upside +27%
Today : $807.71 — upside +3%
Expected +27% · Actual +8% · Reason (≥ +15%) : ✗ No
🎯 on REGN : 80% (5 calls matureds) · 📊 on Health : 52.8% · +1.2% (53 calls)
+8.3%
stock +8% · XLV -4%
matured Sep 15, 22
HC Wainwright & Co. ↗
Aug 2, 21
▲ Buy · 🎯$741
Price at call : $577.13 — upside +28%
Today : $807.71 — upside -8%
Expected +28% · Actual -0% · Reason (≥ +15%) : ✗ No
🎯 on REGN : 80% (5 calls matureds) · 📊 on Health : 52.8% · +1.2% (53 calls)
-0.4%
stock -0% · XLV -1%
matured Aug 2, 22
HC Wainwright & Co. ↗
Jun 29, 21
▲ Buy · 🎯$703
Price at call : $545.98 — upside +29%
Today : $807.71 — upside -13%
Expected +29% · Actual +9% · Reason (≥ +15%) : ✗ No
🎯 on REGN : 80% (5 calls matureds) · 📊 on Health : 52.8% · +1.2% (53 calls)
+9.5%
stock +9% · XLV +2%
matured Jun 29, 22
Argus Research ↗
Mar 12, 20
▲ Buy · 🎯$540
Price at call : $431.89 — upside +25%
Today : $807.71 — upside -33%
Expected +25% · Actual +9% · Reason (≥ +15%) : ✗ No
🎯 on REGN : 75% (8 calls matureds) · 📊 on Health : 55.7% · +2.6% (158 calls)
+9.2%
stock +9% · XLV +35%
matured Mar 12, 21
Argus Research ↗
Feb 11, 20
▲ Buy · 🎯$430
Price at call : $396.75 — upside +8%
Today : $807.71 — upside -47%
Expected +8% · Actual +24% · Reason (≥ +15%) : ✓ Yes
🎯 on REGN : 75% (8 calls matureds) · 📊 on Health : 55.7% · +2.6% (158 calls)
+23.8%
stock +24% · XLV +12%
matured Feb 10, 21
Guggenheim ↗
Sep 23, 19
▲ Buy
Actual +94% · Reason (≥ +15%) : ✓ Yes
🎯 on REGN : 70% (10 calls matureds) · 📊 on Health : 54.6% · +4.4% (97 calls)
+93.9%
stock +94% · XLV +13%
matured Sep 22, 20
Guggenheim ↗
Jan 4, 19
▲ Buy
Actual -6% · Reason (≥ +15%) : ✗ No
🎯 on REGN : 70% (10 calls matureds) · 📊 on Health : 54.6% · +4.4% (97 calls)
-6.5%
stock -6% · XLV +19%
matured Jan 4, 20
Argus Research ↗
Jul 16, 18
▲ Buy · 🎯$415
Price at call : $364.75 — upside +14%
Today : $807.71 — upside -49%
Expected +14% · Actual -18% · Reason (≥ +15%) : ✗ No
🎯 on REGN : 75% (8 calls matureds) · 📊 on Health : 55.7% · +2.6% (158 calls)
-18.2%
stock -18% · XLV +6%
matured Jul 16, 19
▲ Outperform
Actual +47% · Reason (≥ +15%) : ✓ Yes
🎯 on REGN : 50% (6 calls matureds) · 📊 on Health : 54.7% · +5.2% (64 calls)
+46.6%
stock +47% · XLV +12%
matured Jun 29, 17
▲ Outperform · 🎯$475
Price at call : $404.18 — upside +18%
Today : $807.71 — upside -41%
Expected +18% · Actual -2% · Reason (≥ +15%) : ✗ No
🎯 on REGN : 50% (6 calls matureds) · 📊 on Health : 54.7% · +5.2% (64 calls)
-1.7%
stock -2% · XLV -7%
matured Feb 17, 16
Argus Research ↗
Nov 11, 14
▲ Buy
Actual +42% · Reason (≥ +15%) : ✓ Yes
🎯 on REGN : 75% (8 calls matureds) · 📊 on Health : 55.7% · +2.6% (158 calls)
+42.2%
stock +42% · XLV +4%
matured Nov 11, 15
Guggenheim ↗
Oct 2, 14
▲ Buy · 🎯$432
Price at call : $353.69 — upside +22%
Today : $807.71 — upside -47%
Expected +22% · Actual +35% · Reason (≥ +15%) : ✓ Yes
🎯 on REGN : 70% (10 calls matureds) · 📊 on Health : 54.6% · +4.4% (97 calls)
+35.4%
stock +35% · XLV +8%
matured Oct 2, 15
Argus Research ↗
Jul 21, 14
▲ Buy
Actual +84% · Reason (≥ +15%) : ✓ Yes
🎯 on REGN : 75% (8 calls matureds) · 📊 on Health : 55.7% · +2.6% (158 calls)
+84.4%
stock +84% · XLV +26%
matured Jul 21, 15
Frequently asked questions
Should I buy Regeneron Pharmaceuticals stock?
This isn't buy advice. For Regeneron Pharmaceuticals, the analyst consensus is "Buy", with an average price target of $824 (+2% vs the current price). What matters is their past reliability on this stock: the most reliable one is right 100% of the time (11 calls tracked on Regeneron Pharmaceuticals). We show the numbers — you decide.
Is it too late to buy Regeneron Pharmaceuticals? How high can it go?
The most bullish analyst target on Regeneron Pharmaceuticals is $1,030 (+28% above today's price); the average is $824. That's the upside they see. Check how reliable those analysts have actually been on Regeneron Pharmaceuticals on our site before trusting it.
Is Regeneron Pharmaceuticals still a good buy?
The most useful "opinion" isn't an opinion — it's a track record: 36 analysts have a real record on Regeneron Pharmaceuticals, the best hitting 100% over 11 calls. Current consensus: "Buy". Make your call on data, not noise.
Should you invest in Regeneron Pharmaceuticals? The case for and against
The arguments for and against, one by one, from the numbers: why invest in REGN (and why hesitate).
What has Regeneron Pharmaceuticals's past performance been?
Historical returns and a "how much if I had invested" calculator: REGN performance & returns.
What is the best month to buy REGN?
The 12 months ranked by the stock's past returns: best & worst month to buy REGN.
Are insiders buying REGN stock?
Executives' and large holders' buys and sells, decoded: insider buying on REGN.
BIIB 
VRTX 
UNH 
EW 
SRPT 
VEEV 
BSX 
LLY